Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23388995 | 0.95 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL18965690 | 0.95 | SMN1; SMN2 (0.55) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL24419962 | 0.92 | SMN1; SMN2 (0.58) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL22500684 | 0.92 | SMN1; SMN2 (0.58) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| Ethylene Glycol SCHEMBL3791681 | 0.91 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL11526051 | 0.89 | LMNA (0.60) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL1980081 | 0.89 | TSHR (0.60) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL11525596 | 0.89 | LMNA (0.60) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL667486 | 0.88 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL22500950 | 0.88 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108600-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-04-23 | — | — | US | disclosed |
| US-20250041239-A1 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | ISHA Therapeutics LLC (US) | 2025-02-06 | — | — | US | disclosed |
| US-12109303-B2 | Orally dissolving antimicrobial film compositions and methods of their use | ISHA Therapeutics LLC (US) | 2024-10-08 | — | — | US | disclosed |
| WO-2024076715-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-01-18 | — | — | US | disclosed |
| US-20230330012-A1 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | ISHA Therapeutics LLC | 2023-10-19 | — | — | US | disclosed |
| US-20230310350-A1 | ANTIFUNGAL PROPHYLAXIS FOR CORNEA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-10-05 | — | — | US | disclosed |
| US-11684594-B2 | Antifungal prophylaxis for cornea | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230102247-A1 | METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-03-30 | — | — | US | disclosed |
| EP-4142787-A1 | METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS | President And Fellows Of Harvard College (US) | 2023-03-08 | — | — | EP | disclosed |
| US-20140256926-A1 | Ionic Tags for Synthesis of Oligoribonucleotides | HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2014-09-11 | — | — | US | disclosed |
| US-20140256926-A1 | Ionic Tags for Synthesis of Oligoribonucleotides | HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2014-09-11 | — | — | US | disclosed |
| WO-2013026142-A1 | IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2013-02-28 | — | — | WO | disclosed |
| WO-2012024776-A1 | BLOCK SYNTHESIS OF OLIGORIBONUCLEOTIDES | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2012-03-01 | — | — | WO | disclosed |
| US-7914679-B2 | Using miscible liquid extraction fluids; transferring onto surface of microfluid a microdrop under effect of electric field | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2011-03-29 | — | — | US | disclosed |
| US-20100292439-A1 | Use of Functionalized Onium Salts for Peptide Synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE` (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20080185339-A1 | Method For Extracting At Least One Compound From A Liquid Phase Comprising A Functionalized Ionic Liquid, And Microfluidic System For Implementing Said Method | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-08-07 | — | — | US | disclosed |
| EP-1641729-B1 | USE OF FUNCTIONALIZED ONIUM SALTS AS A SOLUBLE SUPPORT FOR ORGANIC SYNTHESIS | CENTRE NAT RECH SCIENT (FR) | 2008-05-07 | — | — | EP | disclosed |
| EP-1641729-A2 | USE OF FUNCTIONALIZED ONIUM SALTS AS A SOLUBLE SUPPORT FOR ORGANIC SYNTHESIS | Centre National De La Recherche Scientifique-CNRS (FR) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005005345-A2 | USE OF FUNCTIONALIZED ONIUM SALTS AS A SOLUBLE SUPPORT FOR ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292439-A1 | Use of Functionalized Onium Salts for Peptide Synthesis | NPY1R, CNKSR1, NPBWR1 | ALDH1A1 4149/4885SMN1; SMN2 3248/4885TSHR 170/4885 |
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ALDH1A1 898/4885SMN1; SMN2 319/4885TSHR 2714/4885 |
| US-20260108600-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | ICOS, ICOSLG, TLR9 | ALDH1A1 4423/4885SMN1; SMN2 1005/4885TSHR 3302/4885 |
| US-20230310350-A1 | ANTIFUNGAL PROPHYLAXIS FOR CORNEA | ERG28, DPM1, CHI3L1 | ALDH1A1 3413/4885SMN1; SMN2 4740/4885TSHR 4654/4885 |
| US-20250041239-A1 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | RAB5IF, CGAS, APOB | ALDH1A1 2777/4885SMN1; SMN2 2784/4885TSHR 4801/4885 |
| US-20230330012-A1 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | RAB5IF, CGAS, APOB | ALDH1A1 2777/4885SMN1; SMN2 2784/4885TSHR 4801/4885 |
| US-20140256926-A1 | Ionic Tags for Synthesis of Oligoribonucleotides | RNGTT, OSTC, OSGEP | ALDH1A1 3379/4885SMN1; SMN2 4198/4885TSHR 2718/4885 |
| US-11684594-B2 | Antifungal prophylaxis for cornea | ERG28, DPM1, CHI3L1 | ALDH1A1 3413/4885SMN1; SMN2 4740/4885TSHR 4654/4885 |
| US-20230102247-A1 | METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS | MYD88, TLR7, TLR9 | ALDH1A1 4776/4885SMN1; SMN2 738/4885TSHR 2967/4885 |
| US-12109303-B2 | Orally dissolving antimicrobial film compositions and methods of their use | RAB5IF, APOB, ERG28 | ALDH1A1 3284/4885SMN1; SMN2 2466/4885TSHR 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.